Patents by Inventor Emeline L. Maillet

Emeline L. Maillet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277568
    Abstract: Methods for treatment for patients suffering from disease or condition are contemplated as including an administration of an intravenous infusion of a pharmaceutically effective amount of psilocybin or psilocin. The intravenous infusion of psilocybin or psilocin may include an additional compound such as a benzodiazepine, preferably lorazepam, administered via a continuous intra-venous infusion. Such methods may be seen to better alleviate the symptoms of psychological conditions, neurological injuries, pain, or inflammatory condition, and may result in reduced need for other medications.
    Type: Application
    Filed: July 12, 2021
    Publication date: September 7, 2023
    Inventors: Ryan Steven BRIDGES, J. Cannon CLIFTON, John Bryan CLIFTON, Neiloufar FAMILY, Emeline L. MAILLET, Shlomi RAZ, David E. NICHOLS, Charles D. NICHOLS
  • Patent number: 9592239
    Abstract: This invention provides a method for treating anxiety-related disorder or impulse control disorder, regulating food intake, attenuating food cravings, or treating anger and/or violence and disorders associated therewith in a patient, comprising administering to the patient in need thereof a therapeutically effective amount of ibogaine, ibogaine derivative, or a pharmaceutically acceptable salt and/or solvate thereof.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: March 14, 2017
    Assignee: DEMERX, INC.
    Inventor: Emeline L. Maillet
  • Publication number: 20160074414
    Abstract: This invention provides a method for treating anxiety-related disorder or impulse control disorder, regulating food intake, attenuating food cravings, or treating anger and/or violence and disorders associated therewith in a patient, comprising administering to the patient in need thereof a therapeutically effective amount of ibogaine, ibogaine derivative, or a pharmaceutically acceptable salt and/or solvate thereof.
    Type: Application
    Filed: March 2, 2015
    Publication date: March 17, 2016
    Inventor: Emeline L. Maillet
  • Publication number: 20130101527
    Abstract: Pharmaceutical compositions or formulations containing octanol are provided. The pharmaceutical compositions are useful for the prevention and treatment of a variety of conditions in mammals including humans, including neurological disorders such as thalamocortical dysrhythmia disorder.
    Type: Application
    Filed: October 14, 2012
    Publication date: April 25, 2013
    Inventors: Rodolfo R. Llinas, Emeline L. Maillet